Identification of a Novel Integrin αvβ3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
CCN1 (CYR61) is a matricellular inducer of angiogenesis essential for successful vascular development. Though devoid of the canonical RGD sequence motif recognized by some integrins, CCN1 binds to, and functions through integrin alphavbeta3 to promote pro-angiogenic activities in activated endothelial cells. In this study we identify a 20-residue sequence, V2 (NCKHQCTCIDGAVGCIPLCP), in domain II of CCN1 as a novel binding site for integrin alphavbeta3. Immobilized synthetic V2 peptide supports alphavbeta3-mediated cell adhesion; soluble V2 peptide inhibits endothelial cell adhesion to CCN1 and the homologous family members CCN2 (connective tissue growth factor, CTGF) or CCN3 (NOV) but not to collagen. These activities are obliterated by mutation of the aspartate residue in the V2 peptide to alanine. The corresponding D125A mutation in the context of the N-terminal half of CCN1 (domains I and II) greatly diminished direct solid phase binding to purified integrin alphavbeta3 and abolished alphavbeta3-mediated cell adhesion activity. Likewise, soluble full-length CCN1 with the D125A mutation is defective in binding purified alphavbeta3 and impaired in alphavbeta3-mediated pro-angiogenic activities in vascular endothelial cells, including stimulation of cell migration and enhancement of DNA synthesis. In contrast, immobilized full-length CCN1-D125A mutant binds alphavbeta3 and supports alphavbeta3-mediated cell adhesion similar to wild type CCN1. These results indicate that V2 is the primary alphavbeta3 binding site in soluble CCN1, whereas additional cryptic alphavbeta3 binding site(s) in the C-terminal half of CCN1 becomes exposed when the protein is immobilized. Together, these results identify a novel and functionally important binding site for integrin alphavbeta3 and provide a new approach for dissecting alphavbeta3-specific CCN1 functions both in cultured cells and in the organism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A mutant CCN1 protein specifically mutated in the αvβ3-binding site is devoid of angiogenic activity [65].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCN1 mutants that disrupt its α6β1-binding sites abolish α6β1-dependent activities without affecting αvβ3-mediated functions [66]. Likewise, disruption of the CCN1 αvβ3-binding site abolishes αvβ3-but not α6β1-mediated activities [65].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This inhibitory effect was observed with both CCN1 and D125A‐CCN1 mutant protein unable to bind αvβ3/αvβ5 [ 23 ] but not with DM‐CCN1 mutant protein[ 27 ] unable to bind integrin α6β1 (Figure 2C).”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“CCN1 does not contain the canonical RGD sequence that can bind a number of integrins [54]. Instead, specific non-canonical binding sites of CCN1 for several integrins have been identified (Fig. 1) [63–66].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Xiong, J.-P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., & Arnaout, M. A. (2002) · Science · doi:10.1126/science.1069040 · Cited by 1,613
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,356
Matricellular proteins: extracellular modulators of cell function
Bornstein, P., & Sage, E. H. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00361-7 · Cited by 965
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
Pierschbacher, M. D., & Ruoslahti, E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45376-8 · Cited by 649
The CCN Family of Angiogenic Regulators: The Integrin Connection
Lau, L. F., & Lam, S. C.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4456 · Cited by 648
Self-citationBork, P. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80155-n · Cited by 627
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family*
Brigstock, D. R. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0360 · Cited by 590
Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., & Lau, L. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6355 · Cited by 495
Self-citationBabic, A. M., Chen, C.-C., & Lau, L. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2958 · Cited by 450
Self-citationCYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity
Mo, F.-E., Muntean, A. G., Chen, C.-C., Stolz, D. B., Watkins, S. C., & Lau, L. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8709-8720.2002 · Cited by 416
Self-citationShimo, T., Nakanishi, T., Nishida, T., Asano, M., Kanyama, M., Kuboki, T., Tamatani, T., Tezuka, K., Takemura, M., Matsumura, T., et al. (1999) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022414 · Cited by 405
Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D., & Imhof, B. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.451 · Cited by 376
NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues
Perbal, B. (2001) · Molecular Pathology · doi:10.1136/mp.54.2.57 · Cited by 348
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library.
Koivunen, E., Gay, D. A., & Ruoslahti, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80715-7 · Cited by 344
Kireeva, M. L., Mo, F.-E., Yang, G. P., & Lau, L. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1326 · Cited by 341
Self-citationExpression of cyr61, a growth factor-inducible immediate-early gene.
O'Brien, T. P., Yang, G. P., Sanders, L., & Lau, L. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3569 · Cited by 310
Self-citationIsolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library
Koivunen, E., Wang, B., & Ruoslahti, E. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.3.373 · Cited by 308
Chen, C.-C., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008087200 · Cited by 305
Self-citationThe Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts
Chen, C.-C., Mo, F.-E., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107666200 · Cited by 300
Self-citationLeu, S.-J., Lam, S. C.-T., & Lau, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209288200 · Cited by 247
Self-citationGao, R., & Brigstock, D. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313204200 · Cited by 242
Schober, J. M., Chen, N., Grzeszkiewicz, T. M., Jovanovic, I., Emeson, E. E., Ugarova, T. P., Ye, R. D., Lau, L. F., & Lam, S. C.-T. (2002) · Blood · doi:10.1182/blood.v99.12.4457 · Cited by 242
Self-citationKireeva, M. L., Latinkić, B. V., Kolesnikova, T. V., Chen, C.-C., Yang, G. P., Abler, A. S., & Lau, L. F. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3548 · Cited by 237
Self-citationTwo RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 231
CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family
Lin, C. G., Leu, S.-J., Chen, N., Tebeau, C. M., Lin, S.-X., Yeung, C.-Y., & Lau, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302028200 · Cited by 214
Self-citationJedsadayanmata, A., Chen, C.-C., Kireeva, M. L., Lau, L. F., & Lam, S. C.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24321 · Cited by 204
Self-citationKireeva, M. L., Lam, S. C.-T., & Lau, L. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3090 · Cited by 203
Self-citationYang, G. P., & Lau, L. F. (1991) · PubMed · Cited by 200
Self-citationChen, N., Chen, C.-C., & Lau, L. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003040200 · Cited by 195
Self-citationComing to grips with integrin binding to ligands
Arnaout, M. A., Goodman, S. L., & Xiong, J.-P. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00371-x · Cited by 192
Cyr61 promotes breast tumorigenesis and cancer progression
Tsai, M.-S., Bogart, D. F., Castañeda, J. M., Li, P., & Lupu, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205682 · Cited by 189
Grzeszkiewicz, T. M., Kirschling, D. J., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100978200 · Cited by 162
Self-citationO'Brien, T. P., & Lau, L. F. (1992) · PubMed · Cited by 161
Self-citationRusnati, M., Tanghetti, E., Dell’Era, P., Gualandris, A., & Presta, M. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.12.2449 · Cited by 147
Xie, D., Miller, C. W., O'Kelly, J., Nakachi, K., Sakashita, A., Said, J. W., Gornbein, J., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009755200 · Cited by 146
Perbal, B., Martinerie, C., Sainson, R., Werner, M., He, B., & Roizman, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.869 · Cited by 145
Ugarova, T. P., Budzynski, A. Z., Shattil, S. J., Ruggeri, Z. M., Ginsberg, M. H., & Plow, E. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36896-6 · Cited by 132
Identification of a novel integrin α6β1 binding site in the angiogenic Inducer CCN1 (CYR61)
Leu, S.-J., Liu, Y., Chen, N., Chen, C.-C., Lam, S. C.-T., & Lau, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305862200 · Cited by 131
Self-citationPeptide Ligands for Integrin .alpha.v.beta.3 Selected from Random Phage Display Libraries
Healy, J. M., Murayama, O., Maeda, T., Yoshino, K., Sekiguchi, K., & Kikuchi, M. (1995) · Biochemistry · doi:10.1021/bi00012a012 · Cited by 124
The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
Men√©ndez, J. A., Mehmi, I., Griggs, D. W., & Lupu, R. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100141 · Cited by 120
Hilfiker, A., Hilfiker-Kleiner, D., Fuchs, M., Kaminski, K., Lichtenberg, A., Rothkötter, H.-J., Schieffer, B., & Drexler, H. (2002) · Circulation · doi:10.1161/01.cir.0000021426.87274.62 · Cited by 114
Temporal Expression of the Chondrogenic and Angiogenic Growth Factor CYR61 During Fracture Repair
Hadjiargyrou, M., Ahrens, W., & Rubin, C. T. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1014 · Cited by 110
Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins
Taverna, D., Moher, H., Crowley, D. G., Borsig, L., Varki, A. P., & Hynes, R. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307289101 · Cited by 110
Connective Tissue Growth Factor Is Increased in Plasma of Type 1 Diabetic Patients With Nephropathy
Roestenberg, P., van Nieuwenhoven, F. A., Wieten, L., Boer, P., Diekman, T., Tiller, A. M., Wiersinga, W. M., Oliver, N., Usinger, W., Weitz, S., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1164 · Cited by 108
Urinary Connective Tissue Growth Factor Excretion in Patients With Type 1 Diabetes and Nephropathy
Gilbert, R. E., Akdeniz, A., Weitz, S., Usinger, W. R., Molineaux, C. J., Jones, S., Langham, R. G., & Jerums, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2632 · Cited by 108
Ball, D. K., A. Surveyor, G., Diehl, J. R., Steffen, C. L., Uzumcu, M., Mirando, M. A., & Brigstock, D. R. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.4.828 · Cited by 96
Cyr61, a deregulated gene in endometriosis
Absenger, Y. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah053 · Cited by 95
McLane, M. A., Vijay‐Kumar, S., Marcinkiewicz, C., Calvete, J. J., & Niewiarowski, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00716-8 · Cited by 86
Schober, J. M., Lau, L. F., Ugarova, T. P., & Lam, S. C.-T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301534200 · Cited by 76
Self-citationLatinkic, B. V. (2001) · Endocrinology · doi:10.1210/en.142.6.2549 · Cited by 61
Self-citationStimulation of Angiogenesis by Cyr61 Gene: A New Therapeutic Candidate
Fataccioli, V., Abergel, V., Wingertsmann, L., Neuville, P., Spitz, E., Adnot, S., Calenda, V., & Teiger, E. (2002) · Human Gene Therapy · doi:10.1089/10430340260185094 · Cited by 58
Tailoring echistatin to possess higher affinity for integrin αIIbβ3
Yamada, T., & Kidera, A. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00409-7 · Cited by 30
Acuña-Cueva, E. R., Hueso‐Ureña, F., Jiménez‐Pulido, S. B., & Moreno‐Carretero, M. N. (2000) · Journal of Molecular Modeling · doi:10.1007/s0089400060433 · Cited by 27
Wu, K. J., Yee, A., Zhu, N. L., Gordon, E. M., & Hall, F. L. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.6.4.433 · Cited by 24
Grzeszkiewicz, T. M. (2002) · Endocrinology · doi:10.1210/en.143.4.1441 · Cited by 23
Self-citation
Research works printed but not linked: 6
- O'Brien, 1992, Cell Growth Differ., 3, 645
- O'Brien, 1990, Mol. Cell. Biol., 10, 3569
- Yang, 1991, Cell Growth Differ., 2, 351
- Brigstock, 1999, Endocr. Rev., 20, 189
- Eliceiri, 2000, Cancer J., 6, 245
- , Grzeszkiewicz, T. M. (2002) Cyr61-induced Cellular Activities in Wound Healing: Impact of Structure on Function. Ph.D. thesis, University of Illinois at Chicago
Cited by
Jun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998
“, whereas its angiogenic activities are mediated through integrin α v β 3 (ref”
BackgroundSelf-citationAll in the CCN family: essential matricellular signaling modulators emerge from the bunker
Leask, A., & Abraham, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03270 · Cited by 655
Functions and mechanisms of action of CCN matricellular proteins
Chen, C.-C., & Lau, L. F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.025 · Cited by 549
“Specific binding sites (black and hatched bars) for several integrins and HSPGs have been identified for CCN1 and CCN2 (Chen et al., 2000; Leu et al., 2003; Chen et al., 2004a; Leu et al., 2004; Gao and Brigstock, 2004; Gao and Brigstock, 2006).”
BackgroundInfluentialSelf-citationThe CCN family of proteins: structure–function relationships
Holbourn, K. P., Acharya, K. R., & Perbal, B. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.07.006 · Cited by 419
CCN1/CYR61: the very model of a modern matricellular protein
Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338
“A mutant CCN1 protein specifically mutated in the avb3-binding site is devoid of angiogenic activity [65].”
BackgroundSelf-citation
Metadata
- Authors
- Chen, N., Leu, S.-J., Todorović, V., Lam, S. C.-T., & Lau, L. F.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Lau, Lester F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 279
- Issue
- 42
- Pages
- 44166-44176
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035497705
- Cited by
- 132
- References
- 60
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 6 · 2015: 6 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5927 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca080080-05)
- National Heart, Lung, and Blood Institute (HL41793)
- National Cancer Institute (CA-80080, R01CA046565, CA-46565)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- CYR61, integrin αvβ3, integrin binding site, matricellular proteins, angiogenesis, endothelial cell adhesion, endothelial cell migration, connective tissue growth factor, CCN3, aspartic acid residues, protein immobilization
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cell Adhesion, Cell Movement, Cells, Cultured, Endothelium, Vascular, Humans, Kinetics, Molecular Sequence Data, Recombinant Proteins, Umbilical Veins, Mutagenesis, Site-Directed, Immediate-Early Proteins, DNA Primers, Neovascularization, Physiologic, Protein Isoforms, Intercellular Signaling Peptides and Proteins, Integrin alphaVbeta3, Mice, Cysteine-Rich Protein 61
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.